About this trial
Around 20% of the obese patients with higher body mass index (BMI) who are taken off the breathing tube and breathing machine (ventilator) end up needing it back to support breathing. The re-application of breathing tube is associated with poor outcomes, including high risk of pneumonia, longer hospital stays, and death. The purpose of this study is to assess if prophylactic use of noninvasive breathing support after removing the breathing tube lowers the chance of needing the breathing tube again.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Adult, age ≥ 18 years old
Receiving invasive mechanical ventilation for ≥24 hours
BMI ≥40 kg/m2
Undergoing planned extubation per treating team
Disqualifiers
Pregnant
Use of extra-corporeal membrane oxygenation
Chronic tracheostomy in place
Unplanned or accidental extubation
Trial design
Parallel
Treatments tested in this trial
Noninvasive ventilation alternating with high flow nasal cannula
DeviceA total of 24 hours of prophylactic respiratory support will be provided using NIV alternating with HFNC with total NIV usage of 16 hours and HFNC usage of 8 hours.
High flow nasal cannula
DeviceA total of 24 hours of prophylactic respiratory support will be provided using HFNC alone.
Treatment groups
Trial outcomes
Primary outcomes
Treatment failure defined by use of rescue respiratory support for acute respiratory failure in the first 72 hours after planned extubation
Rescue respiratory support is defined as reintubation, use of rescue NIV or HFNC use
Secondary outcomes
Reintubation rate
Need for invasive mechanical ventilation within 7 days of extubation
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Rush University Medical Center
Lead sponsor
Hospital Civil de Guadalajara
Collaborator
Medical College of Wisconsin
Collaborator
The University of Texas Health Science Center, Houston
Collaborator
Central DuPage Hospital
Collaborator